Clinical and Economic Outcomes in Low-risk Pulmonary Embolism Patients Treated with Rivaroxaban versus Standard of Care
W. Frank Peacock, Craig I. Coleman, Phil Wells, Gregory J. Fermann, Li Wang, Onur Baser, Jeff Schein, Concetta Crivera
Research output: Contribution to journal › Article › peer-review
1Scopus
citations
Fingerprint
Dive into the research topics of 'Clinical and Economic Outcomes in Low-risk Pulmonary Embolism Patients Treated with Rivaroxaban versus Standard of Care'. Together they form a unique fingerprint.